Ignite Creation Date:
2024-05-06 @ 2:48 PM
Last Modification Date:
2024-10-26 @ 1:37 PM
Study NCT ID:
NCT04434092
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-16
First Post:
2020-06-03
Brief Title:
A Phase III Study Evaluating the Efficacy and Safety of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria PNH Not Previously Treated With Complement Inhibitors
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-10-08
Start Date Type:
ACTUAL
Primary Completion Date:
2022-11-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2028-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2020-06-03
First Submit QC Date:
June 12 2020
Study First Post Date:
2020-06-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2023-11-15
Disp First Submit QC Date:
November 15 2023
Disp First Post Date:
2023-11-18
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-08-12
Last Update Post Date:
2024-05-16
Last Update Post Date Type:
ACTUAL